Flickinger, J. C., Rappaport, J. A., Barton, J. R., Baybutt, T. R., Pattison, A. M., Snook, A. E., & Waldman, S. A. (2021). Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies. Biomark Med.
Citação norma ChicagoFlickinger, John C., Jeffrey A. Rappaport, Joshua R. Barton, Trevor R. Baybutt, Amanda M. Pattison, Adam E. Snook, and Scott A. Waldman. "Guanylyl Cyclase C As a Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies." Biomark Med 2021.
MLA引文Flickinger, John C., et al. "Guanylyl Cyclase C As a Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies." Biomark Med 2021.
警告:這些引文格式不一定是100%准確.